We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
我们分析EMA关于首个口服埃博拉药物的实际建议。关键事实、物流和预测。阅读。
日本药物ensitrelvir在暴露后将COVID-19感染风险降低67%。NEJM发表的III期结果。了解暴露后预防如何起作用。
